Circumventing glucocorticoid-mediated hyperinsulinemia via the activation of PPARα

Cell Cycle

Volumn 8, Issue 15, 2009, Pages 2311-2312

  Bougarne, Nadia ^a   Paumelle, Réjane ^b   Haegeman, Guy ^a   Staels, Bart ^b   De Bosscher, Karolien ^a  

^a GHENT UNIVERSITY   (Belgium)

^b UNIV LILLE   (France)

Author keywords

Cross talk; Glucocorticoid receptor; Hyperinsulinemia; Inflammation; NF B; PPAR; Transcription

Indexed keywords

FENOFIBRATE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST;

ANTIINFLAMMATORY ACTIVITY; CHRONIC INFLAMMATION; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; DRUG RECEPTOR BINDING; DRUG SAFETY; GENE EXPRESSION REGULATION; GENE REPRESSION; GLUCOSE METABOLISM; GROWTH RETARDATION; HEMATOLOGIC MALIGNANCY; HORMONE ACTION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INSULIN RESISTANCE; MENTAL DISEASE; NOTE; PROTEIN FUNCTION; TRANSCRIPTION INITIATION;

EID: 68449085347     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.15.9220     Document Type: Note

References (15)

1. De Bosscher K, et al. Endocr Rev 2003; 24:488-522.
2. Bougarne N, et al. Proc Natl Acad Sci USA 2009; 106:7397-7402
3. Blanquart C, et al. J Steroid Biochem Mol Biol 2003; 85:267-273
4. Chinetti G, et al. Biochem Soc Trans 2006; 34:1128-1131
5. Gilde AJ, et al. J Am Coll Cardiol 2006; 48:24-32.
6. Lefebvre P, et al. J Clin Invest 2006; 116:571-580
7. Staels B, et al. Atherosclerosis 1998; 137:19-23.
8. Schoonjans K, et al. J Lipid Res 1996; 37:907-925
9. Chinetti G, et al. Inflamm Res 2000; 49:497-505.
10. Delerive P, et al. J Biol Chem 1999; 274:32048-32054
11. Staels B, et al. Nature 1998; 393:790-793
12. Shiri-Sverdlov R, et al. J Hepatol 2006; 44:732-741
13. Delerive P, et al. Mol Endocrinol 2002; 16:1029-1039
14. Delerive P, et al. J Biol Chem 2000; 275:36703-36707
15. Ogawa S, et al. Cell 2005; 122:707-721